BeStock  
Stocks › Biotechnology › TARS

Tarsus Pharmaceuticals TARS

US equityMarket cap rank #2295Biotechnology
$73.01 −$4.66 (-6.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $71.00 -2.75%
Open$77.09
Prev close$77.67
Day range$72.57 – $78.11
Volume706.8K
Market cap$3.60B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts8
Average target$105.57+44.6% vs. price
  • Buy 100%
Low $97.00Now $73.01Avg $105.57High $116.00

Recent rating changes

The last 20 actions on file set price targets from $84.00 to $116.00, averaging $101.83.

DateFirmRatingTarget
11 Nov 2026 Barclays BUY $110.00
6 Nov 2026 Mizuho Securities BUY $102.00
4 Nov 2026 BofA Securities BUY –
4 Nov 2026 Guggenheim BUY $97.00
4 Nov 2026 H.C. Wainwright BUY $106.00
4 Nov 2026 Oppenheimer BUY $103.00
29 Oct 2026 Mizuho Securities BUY $94.00
12 Oct 2026 BofA Securities BUY $84.00
9 Oct 2026 Barclays BUY $110.00
2 Oct 2026 Oppenheimer BUY $100.00
24 Sep 2026 Goldman Sachs BUY $116.00
16 Sep 2026 Barclays BUY $110.00
8 Sep 2026 Jefferies BUY $105.00
12 Aug 2026 William Blair BUY –
12 Aug 2026 Oppenheimer BUY $100.00
11 Aug 2026 Mizuho Securities BUY $100.00
8 Aug 2026 LifeSci Capital BUY $104.00
7 Aug 2026 LifeSci Capital BUY $104.00
7 Aug 2026 Mizuho Securities BUY $100.00
7 Aug 2026 H.C. Wainwright BUY $88.00

Discussion

No comments yet — be the first to weigh in on TARS.

Sign in to join the discussion.

Scroll to Top